Cargando…
EPEN-53. C11orf95-RELA REPROGRAMS 3D EPIGENOME IN SUPRATENTORIAL EPENDYMOMA
Ependymoma is the third most common malignant brain tumor in children. However, there is no effective chemotherapy identified and treatment is limited to surgery with or without adjuvant radiation therapy currently. Thus, to develop targeted therapy based on the underlying biology is an urgent need....
Autores principales: | Zhu, Jacqueline Jufen, Jillette, Nathaniel, Li, Xiao-Nan, Cheng, Albert, Lau, Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715536/ http://dx.doi.org/10.1093/neuonc/noaa222.186 |
Ejemplares similares
-
C11orf95-RELA reprograms 3D epigenome in supratentorial ependymoma
por: Zhu, Jacqueline Jufen, et al.
Publicado: (2020) -
EPEN-01. C11ORF95-RELA DICTATES ONCOGENIC TRANSCRIPTIONAL PROGRAMS TO DRIVE AGGRESSIVE SUPRATENTORIAL EPENDYMOMA
por: Arabzade, Amir, et al.
Publicado: (2021) -
EPEN-14. GENERATION OF A C11orf95-RELA FUSION TARGETING ANTIBODY AS A DIAGNOSTIC TOOL FOR SUPRATENTORIAL EPENDYMOMA
por: Ruff, Lisa, et al.
Publicado: (2020) -
EPEN-02. FUNCTION AND DEPENDENCY OF NF-KB ACTIVITY IN C11ORF95-RELA FUSION EPENDYMOMA
por: Stuckert, Austin, et al.
Publicado: (2021) -
EPEN-09. SUPER ENHANCER GENES AS MOLECULAR TARGETS IN C11ORF95-RELA FUSION EPENDYMOMA
por: Bertrand, Kelsey, et al.
Publicado: (2021)